Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Pasic

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Transplantation and Cellular Therapy|March 16, 2026
Ferritin as a pre-transplant biomarker for post-transplant outcomes in allogeneic stem cell transplantation using post-transplant cyclophosphamideSergio Rodriguez-Rodriguez, Caden Chiarello, Nihar Desai, et al.
Transplantation Direct|January 13, 2025
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?Ahmed Alnughmush, Ayman Sayyed, Mats Remberger, et al.
European Journal of Haematology|July 26, 2023
Prognostic implication of pre-transplant FEV<sub>1</sub> on long-term outcomes following allogeneic hematopoietic stem cell transplantationIgor Novitzky-Basso, Wilson Lam, Caden Chiarello, et al.
Oncotarget|November 22, 2014
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancerAlejandro Berlin, Emilie Lalonde, Jenna Sykes, et al.
European Journal of Haematology|June 16, 2024
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomesAyman Sayyed, Leeann Wilson, Vered Stavi, et al.
Bone Marrow Transplantation|February 5, 2024
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignanciesTommy Alfaro Moya, Maria Queralt Salas, Abel Santos Carreira, et al.
Annals of Hematology|October 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survivalSergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux, et al.
European Journal of Haematology|March 18, 2025
Central Nervous System Manifestations of Graft-Versus-Host DiseaseNihar Desai, Niranjan Khaire, Sunu Cyriac, et al.
Transplantation and Cellular Therapy|October 8, 2025
Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell TransplantationCaden Chiarello, Sihath Singhabahu, Mats Remberger, et al.
Blood Advances|November 20, 2024
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantationNihar Desai, Majed Altareb, Mats Remberger, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Transplantation and Cellular Therapy|March 16, 2026
Ferritin as a pre-transplant biomarker for post-transplant outcomes in allogeneic stem cell transplantation using post-transplant cyclophosphamideSergio Rodriguez-Rodriguez, Caden Chiarello, Nihar Desai, et al.
Transplantation Direct|January 13, 2025
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?Ahmed Alnughmush, Ayman Sayyed, Mats Remberger, et al.
European Journal of Haematology|July 26, 2023
Prognostic implication of pre-transplant FEV<sub>1</sub> on long-term outcomes following allogeneic hematopoietic stem cell transplantationIgor Novitzky-Basso, Wilson Lam, Caden Chiarello, et al.
Oncotarget|November 22, 2014
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancerAlejandro Berlin, Emilie Lalonde, Jenna Sykes, et al.
European Journal of Haematology|June 16, 2024
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomesAyman Sayyed, Leeann Wilson, Vered Stavi, et al.
Bone Marrow Transplantation|February 5, 2024
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignanciesTommy Alfaro Moya, Maria Queralt Salas, Abel Santos Carreira, et al.
Annals of Hematology|October 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survivalSergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux, et al.
European Journal of Haematology|March 18, 2025
Central Nervous System Manifestations of Graft-Versus-Host DiseaseNihar Desai, Niranjan Khaire, Sunu Cyriac, et al.
Transplantation and Cellular Therapy|October 8, 2025
Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell TransplantationCaden Chiarello, Sihath Singhabahu, Mats Remberger, et al.
Blood Advances|November 20, 2024
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantationNihar Desai, Majed Altareb, Mats Remberger, et al.
Pageof 10